Please enter your username and password below, if you are not yet a member of Oncology Central remember you can register for free.
Or register via social media
Already have an account? Login here
View our exclusive infographic, which depicts the rationale and design of the ongoing Phase III PIX306 study. This trial has been designed to evaluate the efficacy of pixantrone and rituximab versus gemcitabine and rituximab in patients with diffuse large B-cell lymphoma or follicular grade 3 lymphoma.
The associated Clinical Trial Protocol paper from Future Oncology can be accessed here.